Monopar Therapeutics Inc. · NASDAQ:MNPR
Cittadine Andrew exercised options for 4,384 Monopar Therapeutics Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Cittadine Andrew (Chief Operating Officer) exercised options for 4,384 Monopar Therapeutics Inc. shares, leaving 58,054 shares. Filed Oct 2, 2026 (Form 4).
- Options exercised
- 4,384 shares
- Holding after
- 58,054 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Option exercise | 4,384 | 59,998 | Direct | |
| Sep 30, 2026 | Common Stock | Shares withheld for tax | 1,944 | US$79.67 | 58,054 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Cittadine Andrew
- Monopar Therapeutics Inc. shareholders
- Form 4 · Cittadine Andrew · Jul 2, 2026
- Form 4 · Cittadine Andrew · Apr 2, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026
- Form 4 · Robinson Chandler · Sep 28, 2026